Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA

Published:2010-10-26 Issue:6p1 Volume:32 Page:e222-e228
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:

Author:

BARTLEY P. A.,ROSS D. M.,LATHAM S.,MARTIN-HARRIS M. H.,BUDGEN B.,WILCZEK V.,BRANFORD S.,HUGHES T. P.,MORLEY A. A.

Publisher

Wiley

Subject

Biochemistry, medical,Clinical Biochemistry,Hematology,General Medicine

Reference16 articles.

1. Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemia;Bartley;British Journal of Haematology,2010

2. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease;Bose;Blood,1998

3. Monitoring chronic myeloid leukaemia therapy by real-time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics;Branford;British Journal of Haematology,1999

4. Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations;Branford;Blood,2004

5. BCR-ABL messenger RNA levels continue to decline in patients with chronic phase chronic myeloid leukemia treated with imatinib for more than 5 years and approximately half of all first-line treated patients have stable undetectable BCR-ABL using strict sensitivity criteria;Branford;Clinical Cancer Research,2007

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical validation of the DropXpert S6 system for diagnosis of chronic myelocytic leukemia;Lab on a Chip;2024

2. Disease Response Assessment Modalities in Chronic Myeloid Leukemia: Past, Present, and Future;Indian Journal of Medical and Paediatric Oncology;2023-11-27

3. Molecular characterization of TCF3::PBX1 chromosomal breakpoints in acute lymphoblastic leukemia and their use for measurable residual disease assessment;Scientific Reports;2023-09-13

4. Rapid detection of myeloid neoplasm fusions using single-molecule long-read sequencing;PLOS Global Public Health;2023-09-12

5. The evolution of minimal residual disease: key insights based on a bibliometric visualization analysis from 2002 to 2022;Frontiers in Oncology;2023-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3